Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Single Arm, Open Label, Non-Randomized Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers

NCT05641896 is registered in ClinicalTrials.gov with SOFIE as lead sponsor.

NCT NCT05641896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Single Arm, Open Label, Non-Randomized Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
Lead sponsor
SOFIE
Phase
Phase 2
Overall status
Completed
Start date
April 28, 2023
Completion date
June 30, 2025
Enrollment
112 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, colorectal cancer, gastric cancer, gastrointestinal cancers, hepatocellular carcinoma, pancreatic ductal adenocarcinoma